Medicine and Dentistry
Patient
100%
Prostate Cancer
42%
Therapeutic Procedure
37%
Combination Therapy
24%
Diseases
21%
Transplantation
19%
Neoplasm
18%
Malignant Neoplasm
18%
Cell Transplantation
16%
Hematopoietic Cell
16%
Man
15%
Overall Survival
14%
Inpatient
14%
Survival
13%
Mortality
12%
Age
12%
Progression Free Survival
11%
Diagnosis
10%
Myelofibrosis
10%
Symptom
9%
Breast Cancer
9%
Prostate Specific Antigen
8%
Analysis
8%
Screening
8%
Multiple Myeloma
7%
Cells
7%
Follow up
7%
Blood
7%
Development
6%
Carcinoma
6%
Pilus
6%
Cancer Prevention
6%
Chemotherapy
6%
Biopsy
6%
Association
5%
Chemoprophylaxis
5%
Evaluation Study
5%
Prostatectomy
5%
Cancer
5%
Prostate
5%
Myeloproliferative Neoplasm
5%
Arm
5%
Surgery
5%
Hormone Therapy
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
18%
Diseases
10%
Malignant Neoplasm
10%
Toxicity
8%
Prostate Cancer
7%
Myelofibrosis
7%
Clinical Trial
7%
Survival
7%
Breast Cancer
6%
Ruxolitinib
6%
Chemotherapy
5%
Overall Survival
5%
Multiple Myeloma
5%
Paclitaxel
5%
Nursing and Health Professions
Patient
24%
Prostate Cancer
6%
Transplantation
5%